Jd. Vanbergeijk et al., SOMATOSTATIN DOES NOT ATTENUATE INTESTINAL INJURY IN DEXTRAN SODIUM SULFATE-INDUCED SUBACUTE COLITIS, Mediators of inflammation, 7(3), 1998, pp. 169-173
FROM several in vitro and in vivo studies involvement of somatostatin
(SMS) in intestinal inflammation emerge. Acute colitis induced in rats
is attenuated by the long-acting SMS analogue octreotide, We studied
the potential beneficial effect of SMS on non-acute experimental colit
is, BALB/c mice received either saline, SMS-14 (36 or 120 mu g daily)
or octreotide (3 mu g daily) subcutaneously delivered by implant osmot
ic pumps, A non-acute colitis was induced by administration of dextran
sodium sulphate (DSS) 10% in drinking water during 7 days. DSS evoked
a mild, superficial pancolitis, most characterized by mucosal ulcerat
ion and submucosal influx of neutrophils, Neither SMS-14 nor octreotid
e reduced mucosal inflammatory score or macroscopical disease activity
, although reduction of intestinal levels of interleukin-1 beta (IL-1
beta), IL-6 and IL-10 during DSS was augmented both by SMS and octreot
ide, A slight increase of neutrophil influx was seen during SMS admini
stration in animals not exposed to DSS, In conclusion, SMS or its long
-acting analogue did not reduce intestinal inflammation in non-acute D
SS-induced colitis. According to the cytokine profile observed, SMS-14
and octreotide further diminished the reduction of intestinal macroph
age and Th2 lymphocyte activity.